These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 22994140)
1. Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1. Zheng Y; Gu Q; Xu X Acta Ophthalmol; 2012 Nov; 90(7):e512-23. PubMed ID: 22994140 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a). Zhao H; Jin H; Li Q; Gu Q; Zheng Z; Wu H; Ye S; Sun X; Xu X; Ho PC Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5384-95. PubMed ID: 19515999 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of pathological corneal neovascularization by a small peptide derived from human apolipoprotein (a) Kringle V. Wang Z; Zhao H; Ma JX; Xu X Cornea; 2014 Apr; 33(4):405-13. PubMed ID: 24452210 [TBL] [Abstract][Full Text] [Related]
4. Novel peptide derived from IGF-2 displays anti-angiogenic activity in vitro and inhibits retinal angiogenesis in a model of oxygen-induced retinopathy. Zheng Y; Sun Q; Xu X; Wang W Clin Exp Ophthalmol; 2020 Dec; 48(9):1261-1275. PubMed ID: 33026147 [TBL] [Abstract][Full Text] [Related]
5. β-LGND2, an ERβ selective agonist, inhibits pathologic retinal neovascularization. Giddabasappa A; Eswaraka JR; Barrett CM; Bauler MN; Wu Z; Yepuru M; Miller DD; Dalton JT Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):5066-75. PubMed ID: 22714897 [TBL] [Abstract][Full Text] [Related]
6. Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro. Li F; Bai Y; Zhao M; Huang L; Li S; Li X; Chen Y Ophthalmic Res; 2015; 53(3):109-16. PubMed ID: 25676100 [TBL] [Abstract][Full Text] [Related]
7. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt. Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373 [TBL] [Abstract][Full Text] [Related]
8. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis. You JJ; Yang CH; Huang JS; Chen MS; Yang CM Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485 [TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling. Huang SW; Lien JC; Kuo SC; Huang TF Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611 [TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization. Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312 [TBL] [Abstract][Full Text] [Related]
11. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells. Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222 [TBL] [Abstract][Full Text] [Related]
12. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470 [TBL] [Abstract][Full Text] [Related]
13. Calcitriol is a potent inhibitor of retinal neovascularization. Albert DM; Scheef EA; Wang S; Mehraein F; Darjatmoko SR; Sorenson CM; Sheibani N Invest Ophthalmol Vis Sci; 2007 May; 48(5):2327-34. PubMed ID: 17460298 [TBL] [Abstract][Full Text] [Related]
14. A novel and effective human hepatocyte growth factor kringle 1 domain inhibits ocular neovascularization. Lu Q; Zhang L; Shen X; Zhu Y; Zhang Q; Zhou Q; Gan R; Zhang H; Zhong Y; Xie B Exp Eye Res; 2012 Dec; 105():15-20. PubMed ID: 23085338 [TBL] [Abstract][Full Text] [Related]
15. A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo. Xu Y; Zhao H; Zheng Y; Gu Q; Ma J; Xu X Mol Vis; 2010 Oct; 16():1982-95. PubMed ID: 21031024 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo. Kwon YS; Hong HS; Kim JC; Shin JS; Son Y Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269 [TBL] [Abstract][Full Text] [Related]
17. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related]
18. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice. Kim KL; Suh W Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845 [TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling. Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515 [TBL] [Abstract][Full Text] [Related]
20. Knockout of αA-crystallin inhibits ocular neovascularization. Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]